S. Asbell

1.4k total citations · 1 hit paper
8 papers, 1.1k citations indexed

About

S. Asbell is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Otorhinolaryngology. According to data from OpenAlex, S. Asbell has authored 8 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 2 papers in Radiology, Nuclear Medicine and Imaging and 1 paper in Otorhinolaryngology. Recurrent topics in S. Asbell's work include Lung Cancer Diagnosis and Treatment (4 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Lung Cancer Treatments and Mutations (2 papers). S. Asbell is often cited by papers focused on Lung Cancer Diagnosis and Treatment (4 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Lung Cancer Treatments and Mutations (2 papers). S. Asbell collaborates with scholars based in United States and Canada. S. Asbell's co-authors include John Horton, Diana F. Nelson, W.J. Curran, Andreas Fischbach, J. Stuart Nelson, Robert E. Krisch, Charles Scott, Chia‐Hsien Chang, Marvin Rotman and Alan S. Weinstein and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, International Journal of Radiation Oncology*Biology*Physics and Journal of Neuropathology & Experimental Neurology.

In The Last Decade

S. Asbell

7 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma Trials

1993 1.0k citations W.J. Curran, Charles Scott et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Asbell United States	3	878	505	297	253	151	8	1.1k
Walter Curran United States	5	738 0.8×	404 0.8×	213 0.7×	178 0.7×	195 1.3×	8	940
Kirsten Hopkins United Kingdom	17	864 1.0×	428 0.8×	362 1.2×	197 0.8×	238 1.6×	35	1.4k
Han Hamers Netherlands	10	455 0.5×	367 0.7×	194 0.7×	195 0.8×	121 0.8×	12	776
Y. Tsukada United States	16	588 0.7×	411 0.8×	228 0.8×	277 1.1×	112 0.7×	26	1.3k
Stella Lymberis United States	14	489 0.6×	505 1.0×	206 0.7×	236 0.9×	409 2.7×	49	1.0k
Markus W. Groß Germany	15	290 0.3×	218 0.4×	197 0.7×	295 1.2×	171 1.1×	24	866
Christoph Straube Germany	17	424 0.5×	316 0.6×	251 0.8×	174 0.7×	73 0.5×	41	729
David Pistenmaa United States	14	453 0.5×	829 1.6×	323 1.1×	130 0.5×	104 0.7×	35	1.3k
Michael Prados United States	15	522 0.6×	206 0.4×	105 0.4×	141 0.6×	105 0.7×	39	794
René-Olivier Mirimanoff Switzerland	10	394 0.4×	327 0.6×	124 0.4×	120 0.5×	90 0.6×	15	899

Countries citing papers authored by S. Asbell

Since Specialization

Citations

This map shows the geographic impact of S. Asbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Asbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Asbell more than expected).

Fields of papers citing papers by S. Asbell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Asbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Asbell. The network helps show where S. Asbell may publish in the future.

Co-authorship network of co-authors of S. Asbell

This figure shows the co-authorship network connecting the top 25 collaborators of S. Asbell. A scholar is included among the top collaborators of S. Asbell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Asbell. S. Asbell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Lamond, John P., Sara E. Lally, S. Asbell, et al.. (2012). Experience using frameless fractionated radiosurgery for the treatment of orbital and ocular tumors. Journal of Radiation Oncology. 1(1). 49–55. 1 indexed citations

2.

Grimm, Jimm, Tamara LaCouture, S. Asbell, et al.. (2012). Evaluating Published Skin Dose Tolerance Limits for Stereotactic Body Radiation Therapy of Lung Cancer. Cureus. 2 indexed citations

3.

Nelson, J. Stuart, et al.. (1996). HIGH CELL DENSITY AND NUCLEAR PLEOMORPHISM DO NOT PREDICT SHORTENED SURVIVAL IN OLIGODENDROGLIAL TUMORS. Journal of Neuropathology & Experimental Neurology. 55(5). 638–638. 1 indexed citations

4.

Curran, W.J., Charles Scott, John Horton, et al.. (1993). Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma Trials. JNCI Journal of the National Cancer Institute. 85(9). 704–710. 1026 indexed citations breakdown →

5.

Yousem, David M., Benjamin W. Corn, Charles Scott, et al.. (1993). White matter changes are significantly correlated with rt dose: Observations from a randomized dose escalation trial for malignant glioma (RTOG 83-02). International Journal of Radiation Oncology*Biology*Physics. 27. 206–207. 1 indexed citations

6.

Byhardt, Roger W., S. Asbell, Mack Roach, et al.. (1992). Comparison of Prognostic Factors and Survival Among Black Patients and White Patients Treated With Irradiation for Non-Small-Cell Lung Cancer. JNCI Journal of the National Cancer Institute. 84(22). 1731–1735. 25 indexed citations

7.

Pajak, Thomas F., et al.. (1992). Interruptions of high-dose radiation therapy for non-small cell carcinoma of the lung decrease long-term survival in favorable patients. International Journal of Radiation Oncology*Biology*Physics. 24. 193–194. 7 indexed citations

8.

Pérez, Carlos A., Luther W. Brady, John V. Cox, et al.. (1984). Randomized study to evaluate efficacy of levamisole in patients with unresectable non-oat cell carcinoma of the lung treated with radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 10. 97–98.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact